Large-cap Consumer Discretionary company Haleon has logged a -0.3% change today on a trading volume of 8,055,754. The average volume for the stock is 9,873,985.
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Based in Weybridge, United Kingdom the company has 24,561 full time employees and a market cap of $40,143,085,568. Haleon currently offers its equity investors a dividend that yields 0.8% per year.
The company is now trading -22.3% away from its average analyst target price of $11.6 per share. The 5 analysts following the stock have set target prices ranging from $10.0 to $13.41, and on average give Haleon a rating of buy.
Over the last 12 months HLN shares have declined by -10.7%, which represents a difference of -27.5% when compared to the S&P 500. The stock's 52 week high is $11.42 per share and its 52 week low is $8.71. Based on Haleon's average net margin growth of 2.0% over the last 5 years, its core business remains strong and the stock price may recover in the long term.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 5,694,000 | 754,000 | 13 | 30.0 |
| 2023 | 11,302,000 | 1,111,000 | 10 | 0.0 |
| 2022 | 10,858,000 | 1,119,000 | 10 | -33.33 |
| 2021 | 9,545,000 | 1,439,000 | 15 | 25.0 |
| 2020 | 9,892,000 | 1,181,000 | 12 |
